When people grow old, their immune systems are not as robust. That’s been known for some time. But why? A new research project is aiming 
to answer that question. The project, the result of an NIH grant to the Trudeau Institute, a research center focusing on immune-related conditions, will focus on poor immune response to flu vaccines among seniors. It will look at immune cell vigor and cell messaging that directs front-line immune cells toward their targets. That messaging strength may become weak or disjointed among older people.
Cell messaging–how cells communicate with other cells to steer them toward a target or call them back if they’re not needed–is hugely important and very intriguing. Yet, another source reports that weak immune response among the elderly may be a result of “over-reaction” of immune cells to a virus, a classic immune imbalance scenario.
Who knows? EpiCor certainly has been demonstrated to provide balance in immune response. But it would be really cool if we could somehow see if and/or how the ingredient has an impact on cell messsaging. As I’ve mentioned before, those bacteria and viruses are crafty, cunning little varmints, like they have a mind of their own. Immune cells need to equally be up to the challenge.
